MiraDx

MiraDx Launches PROSTOX™ Standard to Personalize Prostate Cancer Radiation Therapy

Expanding Access to Personalized Radiation Therapy for Prostate Cancer Patients Why do more than 20% of prostate cancer patients experience persistent urinary side effects after radiation therapy? MiraDx, a molecular diagnostics company focused on genetic testing to personalize cancer treatment,…

Read MoreMiraDx Launches PROSTOX™ Standard to Personalize Prostate Cancer Radiation Therapy
Altais Health

Altais Health Solutions and Autonomize AI Streamline Healthcare with AI-Driven Prior Authorization

Strategic Partnership Reduces Administrative Burden and Enhances Operational Efficiency In the rapidly evolving healthcare landscape, how can technology reduce administrative friction while maintaining clinical oversight? Altais Health Solutions and Autonomize AI have demonstrated a compelling answer through their strategic partnership.…

Read MoreAltais Health Solutions and Autonomize AI Streamline Healthcare with AI-Driven Prior Authorization
Healthmine

Healthmine Doubles Sales, Delivers Strong 2025 Care Gap Closure Results

Healthmine’s 2025 Performance Highlights Significant Improvements in Member Engagement and Care Gap Closure In the competitive landscape of health engagement, where measurable outcomes are paramount, Healthmine stands out. The company, known for driving quality, risk, and member experience improvements, has…

Read MoreHealthmine Doubles Sales, Delivers Strong 2025 Care Gap Closure Results
NaphCare

NaphCare Launches Innovative Jail-Based Competency Treatment Program in Nevada

NaphCare Partners with Washoe County Sheriff’s Office to Launch First-of-Its-Kind Program Why is the correctional system struggling to address the growing mental health crisis among detainees? NaphCare, a leading correctional healthcare company, is addressing this critical issue head-on. Partnering with…

Read MoreNaphCare Launches Innovative Jail-Based Competency Treatment Program in Nevada
Angelini

Angelini Pharma and Quiver Bioscience Collaborate to Advance Genetic Epilepsy Therapies

Partnership Aims to Uncover Novel Therapies for Developmental and Epileptic Encephalopathies Why is the discovery of new therapies for genetic epilepsies so critical? Angelini Pharma, part of the privately owned Angelini Industries, and Quiver Bioscience, a discovery technology and therapeutics…

Read MoreAngelini Pharma and Quiver Bioscience Collaborate to Advance Genetic Epilepsy Therapies
Synthekine

Synthekine Inc. Appoints John A. Orwin as Board Chair to Lead Clinical Expansion

Biotech Leader Takes Helm as Synthekine Advances Phase 2 Cancer Study In the rapidly evolving landscape of biotechnology, where precision and innovation are paramount, Synthekine Inc. is making a strategic move to solidify its position. The company, which specializes in engineered cytokine…

Read MoreSynthekine Inc. Appoints John A. Orwin as Board Chair to Lead Clinical Expansion